← back to database
Early-stage deep-technology investor supporting science-based solutions to human and planetary-health challenges emerging from leading California research institutions.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
$35M Fund II + $15M Opportunity Fund
Latest fund vintage
2024
Investing team
David FleckFounder & Managing Partner
Kevin BarrettManaging Partner
How to reach them
Notable investments
Iambic, Hydrosat, Captura, Vogent, Molecular Instruments, Tierra Biosciences, H2U Technologies, Switch Therapeutics